Expression of P185erbB-2, P160erbB-3, P180erbB-4, and heregulin α in human normal bronchial epithelial and lung cancer cell lines

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 481-485

  Al Moustafa, Ala Eddin ^a,c   Alaoui Jamali, Moulay ^b   Paterson, Jesse ^b   O'Connor McCourt, Maureen ^a,c  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Bronchial epithelial cells; Expression; Heregulin ; Lung cancer cells; P160erbB 3; P180erbB 4; P185erbB 2

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; NEU DIFFERENTIATION FACTOR; ONCOPROTEIN; PHOSPHOTYROSINE; RECEPTOR SUBTYPE; TYROSINE KINASE RECEPTOR;

ARTICLE; AUTOPHOSPHORYLATION; BRONCHUS MUCOSA; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUNG CANCER; LUNG CARCINOGENESIS; LUNG CARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

BRONCHI; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; NEUREGULINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; TUMOR CELLS, CULTURED;

EID: 0032898582     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seehurg PH, Libermann TA, Schlessinger J and Francke U: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139, 1985.
2. Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ, and Shoyab M: Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87: 4905-4909, 1990.
3. Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L. Neubauer MG, and Shoyab M: Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90: 1746-1750, 1993.
4. Lupu R, Cardillo M, Harris L, Hijazi M and Rosenberg K: Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance. Semin Cancer Biol 6: 135-145, 1995.
5. Haugen DR, Akslen LA, Varhaug JE, and Lillehaug JR: Expression of c-erbB-2 protein in papillary thyroid carcinomas. Br J Cancer 65: 832-837, 1992.
6. Prigent SA, and Lemoine NR: In progress in growth factor research, eds. Heath JK, Baird A, Dexter M and westermark B(Pergamon, Tarrytown, NY), Vol. 4, pp. 1-24, 1992.
7. Richardson GE, and Johnson BE: The biology of lung cancer. Seminars in Oncology 20: 105-127, 1993.
8. Groenen LC, Nice EC, and Burgess AW: Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors 11: 235-257, 1994.
9. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, and Yarden Y: Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69: 205-216, 1992.
10. Carraway KL, and Cantley LC: A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78: 5-8, 1994.
11. Earp HS, Dawson TL, Li X, and Yu H: Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 35: 115-132, 1995.
12. Pinkas-Kramarski R, Shelly M, Glathe S, Ratzkin BJ, and Yarden Y: Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. J Biol Chem 271: 19029-19032, 1996.
13. Liu C, and Tsao MS: Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines. Am J Pathol 142: 413-23, 1993.
14. Pavelic K, Banjac Z, Pavelic J, and Spaventi S: Evidence for a role of EGF receptor in the progression of human lung carcinoma. Anticancer Res 13: 1133-1137, 1993.
15. Viallet J, Liu C, Emond J, and Tsao MS: Characterization of human bronchial epithelial cells immortalized by the E6 and E7 genes of human papillomavirus type 16. Exp Cell Res 212: 36-41, 1994.
16. Al Moustafa A-E, and Chalifour LE: Immortal cell lines isolated from heart differentiadte to an endothelial cell lineage in the presence of retinoic acid. Cell Growth and Differ 4: 841-847, 1943.
17. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM, and Buckley S: Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 366: 473-475, 1993.
18. Carraway KL, and Burden SJ: Neuregulins and their receptors. Curr Opin Neurobiol 5: 606-612, 1995.
19. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI, Williams WV, Cohen JA, and Kern JA: Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res 50: 421-425, 1990.
20. Quinn CM, Ostrowski JL, Lane SA, Loney DP, Teasdale J, and Benson FA: C-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival. Histopathology 25: 247-252, 1994.
21. Sanidas EE, Filipe MI, Linchan J, Lemoine NR, Gullick WJ, Rajkumar T, and Levison DA: Expression of the c-erbB-3 gene product in gastric cancer. Int J Cancer 54: 935-940, 1993.
22. Myers RB, Srivastava S, Oelschlager DK, and Grizzle WE: Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J Natl Cancer Inst 86: 1140-1145, 1994.
23. Simpson BJ, Phillips HA, Lessells AM, Langdon SP, and Miller WR: C-erbB growth-factor-receptor proteins in ovarian tumours. Int J Cancer 64: 202-206, 1995.
24. Haugen DR, Akslen LA, Varhaug JE, and Lillehaug JR: Expression of c-erbB-3 and c -erbB-4 proteins in papillary thyroid carcinomas; Cancer Res 56: 1184-1188, 1996.
25. Tsao MS, Zhu H, and Viallet J: Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells. Exp Cell Res 223: 268-273, 1996.
26. Moody TW: Peptides and growth factors in non-small cell lung cancer. Peptides 17: 545-555, 1996.
27. Zhang K, Sun J, Liu N, Wen D, Chang D, Thomason A and Yoshinaga SK: Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J Biol Chem 271: 3884-3890, 1996.
28. Ethier SP, Langton BC, and Dilts CA: Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Mol Carcinog 15: 134-143 , 1996.
29. Normanno N, Kim N, Wen D, Smith K, Harris AL, Plowman G, Colletta G, Ciardiello F, and Salomon DS: Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas. Breast Cancer Res Treat 35: 293-297, 1995.